Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Regulatory News

Date Source Headline
24th Dec 2009 7:01 am RNS Complete Response Letter on Motavizumab
23rd Dec 2009 3:00 pm RNS Acquisition
16th Dec 2009 7:00 am RNS FDA AdCom favourable vote on Crestor
11th Dec 2009 3:56 pm RNS FDA posts Crestor briefing materials
8th Dec 2009 4:00 pm RNS Holding(s) in Company
4th Dec 2009 7:00 am RNS FDA clears Seroquel XR as add-on for MDD
3rd Dec 2009 7:00 am RNS AstraZeneca and Targacept licencing deal
1st Dec 2009 4:00 pm RNS Total Voting Rights
19th Nov 2009 7:00 am RNS US NDA submitted for Brilinta
2nd Nov 2009 4:00 pm RNS Total Voting Rights
30th Oct 2009 3:30 pm RNS Director/PDMR Shareholding
29th Oct 2009 11:00 am RNS 3rd Quarter Results - Part 2 of 2
29th Oct 2009 11:00 am RNS 3rd Quarter Results - Part 1 of 2
28th Oct 2009 9:00 am RNS Notice of Results
28th Oct 2009 7:00 am RNS ZACTIMA
6th Oct 2009 4:30 pm RNS Holding(s) in Company
5th Oct 2009 2:39 pm RNS Onglyza EU marketing authorisation
1st Oct 2009 4:00 pm RNS Total Voting Rights
28th Sep 2009 7:00 am RNS US court affirms Seroquel summary judgment
21st Sep 2009 11:00 am RNS AstraZeneca development deal with Nektar
8th Sep 2009 4:30 pm RNS Director/PDMR Shareholding
4th Sep 2009 4:19 pm RNS Publication of Prospectus
1st Sep 2009 3:00 pm RNS Director/PDMR Shareholding
1st Sep 2009 11:00 am RNS Total Voting Rights
1st Sep 2009 7:00 am RNS PLATO
26th Aug 2009 4:00 pm RNS Director/PDMR Shareholding
3rd Aug 2009 7:00 am RNS FDA approves Onglyza for type 2 diabetes
31st Jul 2009 4:45 pm RNS Total Voting Rights
31st Jul 2009 4:30 pm RNS Director/PDMR Shareholding
30th Jul 2009 11:00 am RNS Half Yearly Report - Part 3 of 3
30th Jul 2009 11:00 am RNS Half Yearly Report - Part 2 of 3
30th Jul 2009 11:00 am RNS Half Yearly Report - Part 1 of 3
29th Jul 2009 9:00 am RNS Notice of Results
29th Jul 2009 7:00 am RNS AstraZeneca to progress CytoFab into Phase IIb
9th Jul 2009 2:06 pm RNS AZ terminates MAP agreement
1st Jul 2009 5:34 pm RNS Director/PDMR Shareholding
1st Jul 2009 7:00 am RNS IRESSA EU approval
30th Jun 2009 5:26 pm RNS Total Voting Rights
26th Jun 2009 7:00 am RNS ONGLYZA CHMP positive opinion
11th Jun 2009 7:00 am RNS FDA AdCom recommendation on Seroquel
FTSE 100 Latest
Value9,148.45
Change18.74